Compugen Stock Analysis
| CGEN Stock | USD 1.84 0.09 4.66% |
IPO Date 11th of August 2000 | 200 Day MA 1.5913 | 50 Day MA 1.6944 | Beta 2.855 |
Compugen holds a debt-to-equity ratio of 0.024. At this time, Compugen's Short Term Debt is very stable compared to the past year. As of the 1st of February 2026, Net Debt To EBITDA is likely to grow to 1.62, while Net Debt is likely to drop (14.5 M). With a high degree of financial leverage come high-interest payments, which usually reduce Compugen's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Compugen's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Compugen's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Compugen Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Compugen's stakeholders.
For most companies, including Compugen, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Compugen, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Compugen's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 4.1191 | Enterprise Value Ebitda (19.16) | Price Sales 25.0912 | Shares Float 91.6 M | Wall Street Target Price 5.8 |
Compugen is undervalued with Real Value of 2.84 and Target Price of 5.8. The main objective of Compugen stock analysis is to determine its intrinsic value, which is an estimate of what Compugen is worth, separate from its market price. There are two main types of Compugen's stock analysis: fundamental analysis and technical analysis.
The Compugen stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Compugen is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Compugen Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. Compugen Stock Analysis Notes
About 14.0% of the company shares are held by institutions such as insurance companies. The book value of Compugen was currently reported as 0.47. The company recorded a loss per share of 0.29. Compugen had not issued any dividends in recent years. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. Compugen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 73 people. For more info on Compugen please contact Anat CohenDayag at 972 3 765 8585 or go to https://cgen.com.Compugen Investment Alerts
| Compugen may become a speculative penny stock | |
| Compugen had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 27.86 M. Net Loss for the year was (14.23 M) with profit before overhead, payroll, taxes, and interest of 513 K. | |
| Latest headline from finance.yahoo.com: Compugen Partners with AXL to Support Canadas AI Commercialization |
Compugen Largest EPS Surprises
Earnings surprises can significantly impact Compugen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2011-11-08 | 2011-09-30 | -0.09 | -0.1 | -0.01 | 11 | ||
2011-05-11 | 2011-03-31 | -0.07 | -0.06 | 0.01 | 14 | ||
2010-02-09 | 2009-12-31 | -0.08 | -0.07 | 0.01 | 12 |
Compugen Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 173.2 M.Compugen Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.14) | (0.15) | |
| Return On Capital Employed | (0.14) | (0.15) | |
| Return On Assets | (0.14) | (0.15) | |
| Return On Equity | (0.30) | (0.31) |
Management Efficiency
Compugen has return on total asset (ROA) of (0.1818) % which means that it has lost $0.1818 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5295) %, meaning that it created substantial loss on money invested by shareholders. Compugen's management efficiency ratios could be used to measure how well Compugen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of February 2026, Return On Tangible Assets is likely to drop to -0.15. In addition to that, Return On Capital Employed is likely to drop to -0.15. At this time, Compugen's Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.71 | 0.67 | |
| Tangible Book Value Per Share | 0.71 | 0.67 | |
| Enterprise Value Over EBITDA | (9.71) | (10.20) | |
| Price Book Value Ratio | 2.24 | 3.62 | |
| Enterprise Value Multiple | (9.71) | (10.20) | |
| Price Fair Value | 2.24 | 3.62 | |
| Enterprise Value | 109.5 M | 146.1 M |
Compugen benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Technical Drivers
As of the 1st of February, Compugen shows the Risk Adjusted Performance of 0.042, mean deviation of 2.9, and Downside Deviation of 3.39. Compugen technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Compugen Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Compugen price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
Compugen Outstanding Bonds
Compugen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Compugen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Compugen bonds can be classified according to their maturity, which is the date when Compugen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Compugen Predictive Daily Indicators
Compugen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Compugen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Compugen Forecast Models
Compugen's time-series forecasting models are one of many Compugen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Compugen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Compugen Bond Ratings
Compugen financial ratings play a critical role in determining how much Compugen have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Compugen's borrowing costs.| Piotroski F Score | 6 | Healthy | View |
| Beneish M Score | (7.18) | Unlikely Manipulator | View |
Compugen Debt to Cash Allocation
As Compugen follows its natural business cycle, the capital allocation decisions will not magically go away. Compugen's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Compugen currently holds 2.91 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Compugen has a current ratio of 6.04, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Compugen's use of debt, we should always consider it together with its cash and equity.Compugen Total Assets Over Time
Compugen Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Compugen uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Compugen Debt Ratio | 3.07 |
Compugen Corporate Bonds Issued
Compugen Net Debt
About Compugen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Compugen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Compugen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Compugen. By using and applying Compugen Stock analysis, traders can create a robust methodology for identifying Compugen entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.31) | (0.33) | |
| Operating Profit Margin | (0.48) | (0.51) | |
| Net Loss | (0.46) | (0.48) | |
| Gross Profit Margin | 0.82 | 0.87 |
Current Compugen Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Compugen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Compugen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 5.8 | Strong Buy | 4 | Odds |
Most Compugen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Compugen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Compugen, talking to its executives and customers, or listening to Compugen conference calls.
Compugen Stock Analysis Indicators
Compugen stock analysis indicators help investors evaluate how Compugen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Compugen shares will generate the highest return on investment. By understating and applying Compugen stock analysis, traders can identify Compugen position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 14.3 M | |
| Common Stock Shares Outstanding | 89.5 M | |
| Total Stockholder Equity | 54.9 M | |
| Total Cashflows From Investing Activities | -46.3 M | |
| Tax Provision | 4.5 M | |
| Property Plant And Equipment Net | 3.7 M | |
| Cash And Short Term Investments | 103.3 M | |
| Cash | 18.2 M | |
| Accounts Payable | 1.8 M | |
| Net Debt | -15.3 M | |
| 50 Day M A | 1.6944 | |
| Total Current Liabilities | 20.2 M | |
| Other Operating Expenses | 42.8 M | |
| Non Current Assets Total | 9 M | |
| Non Currrent Assets Other | 5.3 M | |
| Stock Based Compensation | 3 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Will Life Sciences Tools & Services sector continue expanding? Could Compugen diversify its offerings? Factors like these will boost the valuation of Compugen. Projected growth potential of Compugen fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Compugen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.29) | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets | Return On Equity |
Investors evaluate Compugen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Compugen's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Compugen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Compugen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Compugen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Compugen's market price signifies the transaction level at which participants voluntarily complete trades.